Drugs - 3
V03AB14 | Protamine | Solution for Injection | 50 mg/5 ml
Angebotsfrist:26. Mai 2026
Typ:Ausschreibung
Ohne Kreditkarte · Sofortiger Zugang
Inhalt auf einen Blick
V03AB14 | Protamine | Solution for Injection | 50 mg/5 ml
- Ausschreibungstyp: Ausschreibung
- Auftraggeber: PHI University Clinic for Hematology Skopje
- Veröffentlicht: 28. April 2026
- Frist: 26. Mai 2026
Ausschreibungsbeschreibung
V03AB14 | Protamine | Solution for Injection | 50 mg/5 ml
Weiterführende Details
Nach Registrierung stehen Unterlagen, Fristen und Hinweise zur Einreichung strukturiert bereit.
- Kernanforderungen der Ausschreibung priorisiert aufbereitet
- Fristen, Eignungskriterien und Unterlagen in einem Ablauf
- Hinweise zur strukturierten Angebotsvorbereitung
- Passende Folgeausschreibungen automatisch entdecken
Dokumente und Anhänge
49 Dateien erfasst- PDF Notice (BUL)
- PDF Notice (SPA)
- PDF Notice (CES)
- PDF Notice (DAN)
- PDF Notice (DEU)
- PDF Notice (EST)
Ähnliche Bekanntmachungen
10- University Clinic of ENT – SkopjeSkopjeFrist: 30. Apr.
Medications and infusion solutions
A02BA03 famotidine lyophilisate for solution for injection 20mg A02BC02 PANTOPRAZOLE powder for solution for injection/ powder for solution for injection or infusion 40 mg A03BA01 ATROPINE solution for injection 0.5mg/1ml A03BA01 ATROPINE solution for injection 1mg/1ml A03FA01 METOCLOPRAMIDE Amp (10.00mg)/2.00ml solution for injection 10 mg/2 ml A04AA01 ONDANSETRON solution for injection 4 mg/2 ml A10AB05 insulin aspart solution for injection 100 U/1 ml A11DA01 THIAMINE solution for injection 100mg/ml A11GA01 ASCORBIC ACID solution for injection 500mg/5ml A11HA02 PYRIDOXINE solution for injection 10% A12AA03 CALCIUM GLUCONATE solution for infusion/ solution for injection 10% B01AB06 NADROPARIN pre-filled syringe x 0.4 ml with needles (27 G x 0.4 mm)/box 3,800 IU/0.4ml (0.4ml) B01AB06 NADROPARIN pre-filled syringe x 0.3 ml with needles (27 G x 0.4 mm)/box 2850 IU anti-Xa/0.3 ml B01AB06 NADROPARIN pre-filled syringe x 0.6 ml with needles (27 G x 0.4 mm)/box 5700 IU anti-Xa/0.6 ml B02AA02 tranexamic acid solution for injection 500 mg/5 ml B02BA01 PHYTOMENADIONE injection solution 10mg/1ml B05BA03 Dextrose injection solution 35% B05XA05 magnesium sulfate injection solution 150 mg/ ml C01AA05 digoxin injection or infusion solution 0.25 mg/2 ml C01BD01 AMIODARONE injection or infusion solution/ injection solution 150mg/3ml C01CA24 EPINEPHRINE injection solution/ injection or infusion solution 1mg/1ml C01CA26 EPHEDRINE injection solution 30 mg/10ml C02CA06 URAPIDIL injection solution 25 mg/5 ml C03CA01 FUROSEMIDE injection solution 20 mg/2 ml C07AB09 Esmolol injection solution 100 mg/10 ml C08DA01 VERAPAMIL solution for injection 5mg/2ml C09AA02 ENALAPRILAT solution for injection 1.25 mg/1 ml G04BD09 TROSPIUM solution for injection 0.2 mg/5 ml H02AB02 DEXAMETHASONE solution for injection 4mg/1ml H02AB04 METHYLPREDNISOLONE/ METHYLPREDNISOLONE SUCCINATE NATRIUM powder and vehicle for solution for injection or infusion/ powder and vehicle for solution for injection 20mg (20 mg/1 ml) vial+ampoule/ ampoule+ampoule H02AB04 METHYLPREDNISOLONE/ METHYLPREDNISOLONE SUCCINATE NATRIUM powder and vehicle for solution for injection or infusion/ powder and vehicle for solution for injection 40mg (40 mg/1 ml) vial+ampoule/ ampoule+ampoule H02AB09 HYDROCORTISONE lyophilisate for solution for injection/ powder and vehicle for solution for injection or infusion/ powder and vehicle for solution for injection 100 mg/ml H02AB09 HYDROCORTISONE lyophilisate for solution for injection/ powder and vehicle for solution for injection or infusion/ powder and vehicle for solution for injection 100 mg/ml J01DH51 IMIPENEM/CILASTATIN powder for solution for injection 500 mg/500 mg vial J01DD04 CEFTRIAXONE powder for solution for injection/ powder and vehicle for solution for injection 1000 mg (1g) J01DD04 CEFTRIAXONE powder for solution for injection/ powder and vehicle for solution for injection 2000 mg (2g) J01DH02 meropenem powder for solution for injection or infusion 500 mg J01DH02 meropenem powder for solution for injection or infusion 1000 mg 35 J01FA10 AZITHROMYCIN powder for solution for infusion 500 mg J01FF01 CLINDAMYCIN solution for injection 300mg/ 2ml J01FF01 CLINDAMYCIN solution for injection 600mg/ 4ml J01GB03 GENTAMICIN solution for injection "120 mg/ 2 ml; 120 mg/ 1.5 ml" J01GB03 GENTAMICIN solution for injection 80 mg/ 2 ml J01GB06 AMIKACIN solution for injection or infusion 500 mg/2 ml J01MA02 CIPROFLOXACIN concentrate for solution for infusion 100mg/10ml J01XA01 VANCOMYCIN powder for solution for infusion 500 mg J01XA01 VANCOMYCIN powder for solution for infusion 1000 mg J01XB01 colistin (colistimethate) powder for solution for injection, infusion or inhalation 1 MIE M01AE03 KETOPROFEN solution for injection/ solution for injection or infusion 100mg/2ml M01AE17 dexketoprofen solution for injection 50 mg/2 ml M03AB01 SUXAMETHONIUM solution for injection/ solution for injection or infusion 50mg/1ml M03AC04 ATRACURIUM solution for injection 50mg/5ml M03AC09 ROCURONIUM BROMIDE solution for injection 50 mg/5 ml N01AH01 FENTANYL solution for injection 50mcg/1ml ampoule x 2ml N01AH01 FENTANYL solution for injection 50mcg/1ml ampoule x 10ml N01AH06 REMIFENTANIL powder for concentrate for solution for infusion 2 mg N01AX07 ETOMIDATE solution for injection or infusion 20mg/10ml N01AX10 PROPOFOL emulsion for injection or infusion 10 mg/1ml N01BB02 LIDOCAINE solution for injection 50ml ampoule N01BB02 LIDOCAINE HYDROCHLORIDE 2% solution for injection 20 mg/mL N01BB52 LIDOCAINE EPINEPHRINE solution for injection (40 mg/0.025 mg)/2 ml N02AX02 tramadol solution for injection 50 mg/1 ml N02BB02 METAMIZOLE SODIUM solution for injection 1 g/2 ml N02BB02 METAMIZOLE SODIUM solution for injection 2.5 g/5 ml N05AA03 promazine solution for injection 50 mg / ml N05AL01 sulpiride solution for injection 100 mg/2 ml N05BA01 DIAZEPAM solution for injection or infusion/ solution for injection 10mg/2ml N05CD08 MIDAZOLAM solution for injection "1mg/1 ml N07AA01 NEOSTIGMINE solution for injection 0.5mg/1ml R03DA05 AMINOPHYLLINE solution for injection 250mg/10ml R06AC03 CHLOROPYRAMINE solution for injection 20 mg/2 ml V03AB15 NALOXONE solution for injection/ solution for injection or infusion 0.4mg/1ml V03AB25 FLUMAZENIL solution for injection or infusion/ solution for injection 0.5mg/5ml V03AB35 SUGAMMADEX solution for injection 100 mg/ml A02BC02 pantoprazole gastro-resistant tablet 40 mg A02BC03 LANSOPRAZOLE gastro-resistant capsule, hard 30 mg A07AX03 nifuroxazide capsule, hard 200 mg C03AA03 HYDROCHLOROTHIAZIDE tablet 25 mg C03CA01 FUROSEMIDE tablet 40 mg C08CA05 nifedipine film-coated tablet, prolonged release 20 mg C09AA02 ENALAPRIL tablet 10 mg C09AA02 ENALAPRIL tablet 20 mg C09AA03 LISINOPRIL tablet 20 mg C09AA03 LISINOPRIL tablet 10 mg H02AB06 PREDNISOLONE tablet 20 mg H02AB06 PREDNISOLONE tablet 50 mg J01CR02 AMOXICILLIN, CLAVULANIC ACID film-coated tablet/ tablet for oral suspens
- PHI Clinical Hospital TetovoTetovoFrist: 23. März
Medicines from the positive list
Pantoprazole powder for solution for injection/powder for solution for injection or infusion 40 mg
- PHI University Clinic for Hematology SkopjeSkopjeFrist: 26. März
Drugs
L01XX27 Arsenic trioxide concentrate for solution for infusion 2mg/ml(6ml) Vial 500
- PHI University Clinic for Hematology SkopjeSkopjeFrist: 26. Mai
Drugs - 3
A02BA03 Famotidine film-coated tablet 40 mg
- Department of ContractsFloriana
CT2017/2026 - Framework Contract for the supply of Azacitidine 25mg/mL Powder for Suspension for Injection
CT2017/2026 - Framework Contract for the supply of Azacitidine 25mg/mL Powder for Suspension for Injection
- Department of ContractsFloriana
CT2062/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF NATALIZUMAB SOLUTION FOR INJECTION/ INFUSION
CT2062/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF NATALIZUMAB SOLUTION FOR INJECTION/ INFUSION
- Department of ContractsFlorianaFrist: 25. Mai
CT2077/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF METHOTREXATE SOLUTION FOR INJECTION IN PRE-FILLED PENS
CT2077/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF METHOTREXATE SOLUTION FOR INJECTION IN PRE-FILLED PENS
- Department of ContractsFloriana
CT2320/2025 - FRAMEWORK CONTRACT FOR THE SUPPLY OF CETUXIMAB 5MG/ML SOLUTION FOR INFUSION
CT2320/2025 - FRAMEWORK CONTRACT FOR THE SUPPLY OF CETUXIMAB 5MG/ML SOLUTION FOR INFUSION
- Finnish Institute for Health and WelfareHelsinki
Azithromycin oral suspension 40 mg/ml - SUSPENDED
Ausschreibung der Finnish Institute for Health and Welfare (THL) für Azithromycin orale Suspension 40 mg/ml (15 ml, ATC J01FA10) für das rescEU Medical-Projekt. Vergabe an einen Lieferanten anhand des wirtschaftlich günstigsten Angebots. Menge ist in Anhang 7 (restricted, TL IV) spezifiziert. Zusätzlich besteht eine Option auf Bezug von bis zu 100 % der ursprünglichen Menge, die bis Ende September 2028 ausgeübt werden kann. Lieferplanung für die Option wird separat vereinbart. Alle Zeiten finnische Ortszeit.
- Agency for Real Estate CadastreSkopjeFrist: 06. Apr.
Solution for automated detection and response to security events on infrastructure endpoints for a period of 3 years
solution for automated detection and response to security events on infrastructure endpoints for a period of 3 years
Häufige Fragen zu dieser Ausschreibung
- Wie kann ich mich auf diese Ausschreibung bewerben?
- Erstellen Sie ein kostenloses Konto auf auftrag.ai. Danach sehen Sie alle Unterlagen, Fristen und Hinweise zur Einreichung in einem strukturierten Ablauf.
- Bis wann läuft die Angebotsfrist?
- Die Angebotsfrist endet am 26. Mai 2026.
- Wer ist der Auftraggeber?
- Der Auftraggeber ist PHI University Clinic for Hematology Skopje.
- Welche Unterlagen sind für den Start relevant?
- In der Regel benötigen Sie Leistungsbeschreibung, Eignungsnachweise, Fristenhinweise und ggf. Formblätter. Auf auftrag.ai werden diese Punkte priorisiert dargestellt.